Handbook of Lipids in Human Function

Table of Contents

Chapter 1: Personalized Diet and Lifestyle Interventions on Lipids and Lipoproteins
Chapter 2: Trans Fats and Risks of Cardiovascular Diseases: Facts or Artifacts?
Chapter 3: Fatty Acids and Cardiac Ischemia Reperfusion Injury
Chapter 4: Lipids Nutrition and Epigenetic Modification in Obesity-Related Co-Morbitities
Chapter 5: Dairy Products: Their Role in the Diet and Effects on Cardiovascular Disease
Chapter 6: Fatty Acids in Corn Oil: Role in Heart Disease Prevention
Chapter 7: Dietary Approaches to Reduce Aortic Stiffness
Chapter 8: Inflammation and Atherogenic Effects Due to Saturated Fatty Acids
Chapter 9: The Use of Omega-3 Polyunsaturated Fatty Acids (n-3 PUFAs) in Atrial Fibrillation
Chapter 10: Individual Fatty Acids in Cardiometabolic Disease
Chapter 11: Omega-3 Polyunsaturated Fatty Acids in Patients with Coronary Disease Treated with Percutaneous Coronary Intervention
Chapter 12: Effects of Omega-3 Fatty Acid Supplementation on Cognition in Children
Chapter 13: The Effects of Glycerophospholipids and Fatty Acids on APP Processing: Implications for Alzheimer's Disease
Chapter 14: Role of Dietary Fatty Acids in Mood Disorders
Chapter 15: Biochemical Aspects of n-6 and n-3 Fatty Acid-Derived Lipid Mediators in the Brain
Chapter 16: Neurocognitive Functions and Lipids
Chapter 17: What Are the Physiological Roles of Mead Acid (5,8,11-Eicosatrienoic Acid)?
Chapter 18: Fat Metabolism During Exercise and Dietary Interventions for Enhancing Fat Metabolism and Athletic Performance
Chapter 19: Ruminal Metabolism of Fatty Acids: Modulation of Polyunsaturated, Conjugated, and Trans Fatty Acids in Meat and Milk
Chapter 20: Lipids and Metabolic Syndrome
Chapter 21: Fatty Acids and Hypothalamic Dysfunction in Obesity
Chapter 22: Dietary Lipid Determines the Health of Airway Epithelia and the Lungs
Chapter 23: Oleic Acid and Lung Injury
Chapter 24: Dietary Fats and Inflammation
Chapter 25: Intensive Lipid-Lowering Treatment in Patients with Inflammatory Joint Diseases
Chapter 26: Arachidonic Acid and Cancer Risk
Chapter 27: Blood Cell Membrane Omega-3 (n-3) Fatty Acid Abnormality and Supplementation in Patients with Sickle Cell Anemia
Chapter 28: Lipids, Low-Grade Chronic Inflammation and NAFLD: A Menage A Trois?
Chapter 29: Disturbances of Lipid Metabolism in a Cancer Cell and How This Knowledge Increases Its Role in Clinical Oncology

Authors

Watson, Ronald Ross Ronald Ross Watson, PhD, is Professor of Health Promotion Sciences at the University of Arizona, Mel and Enid Zuckerman College of Public Health. Dr. Watson began his research in public health at the Harvard School of Public Health as a Fellow in 1971 doing field work on vaccines in Saudi Arabia. He has done clinical studies in Colombia, Iran, Egypt, Saudi Arabia and the United States which provides a broad international view of public health. He has served in the military reserve hospital for 17 years with extensive training in medical responses to disasters as the chief biochemistry officer of a general hospital, retiring as a Lt. Colonel. He is a distinguished member of several national and international nutrition, immunology, and cancer societies. Dr. Watson's career has involved studying many lifestyle aspects for their uses in health promotion. He has edited over 100 biomedical reference books and 450 papers and chapters. His teaching and research focuses on alcohol, tobacco, and drugs of abuse in heart function and disease in mouse models. De Meester, Fabien Fabien De Meester PhD is a biochemist, owner and managing director of DMF, a company invested in the promotion of body/mind health at people management levels. His long expertise in protein and lipid chemistry derives from his day-to-day consulting activities within enterprises around the world. It provides him with the visionary approach needed to implement changes in use and importance of fatty acids.